Literature DB >> 24050274

Allosteric modulation and functional selectivity of G protein-coupled receptors.

Zhan-Guo Gao, Kenneth A Jacobson.   

Abstract

Agonists of a single G protein-coupled receptor (GPCR) may activate distinct signaling pathways. Functional selectivity, an emerging concept with therapeutic relevance for GPCRs, may be due to conformational selection or stabilization with respect to particular agonists, receptor dimerization, variable expression levels of GPCRs and downstream signaling molecules, and allosteric modulation. Allosteric modulators may have potential advantages over orthosteric ligands, including greater selectivity and safety. This review focuses on functional selectivity resulting from allosteric modulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24050274      PMCID: PMC3653340          DOI: 10.1016/j.ddtec.2012.08.004

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  43 in total

1.  Comparing label-free biosensors for pharmacological screening with cell-based functional assays.

Authors:  Matthew F Peters; François Vaillancourt; Madeleine Heroux; Manon Valiquette; Clay W Scott
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

2.  Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.

Authors:  Zhan-Guo Gao; Dennis Verzijl; Annelien Zweemer; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-06-21       Impact factor: 5.858

3.  A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569.

Authors:  Jonathan F Fay; David L Farrens
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

4.  HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.

Authors:  François Degorce; Amy Card; Sharon Soh; Eric Trinquet; Glenn P Knapik; Bing Xie
Journal:  Curr Chem Genomics       Date:  2009-05-28

5.  Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2008-03-08       Impact factor: 7.658

Review 6.  Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Carrie K Jones; Craig W Lindsley
Journal:  Trends Pharmacol Sci       Date:  2009-02-07       Impact factor: 14.819

Review 7.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Arthur Christopoulos; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

8.  The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?

Authors:  Vanessa M Muniz-Medina; Stacey Jones; Jodi M Maglich; Cristin Galardi; Robert E Hollingsworth; Wieslaw M Kazmierski; Robert G Ferris; Mark P Edelstein; Karen E Chiswell; Terry P Kenakin
Journal:  Mol Pharmacol       Date:  2008-12-08       Impact factor: 4.436

9.  Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code.

Authors:  Adrian J Butcher; Rudi Prihandoko; Kok Choi Kong; Phillip McWilliams; Jennifer M Edwards; Andrew Bottrill; Sharad Mistry; Andrew B Tobin
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

10.  Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.

Authors:  Zhan-Guo Gao; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  BMC Pharmacol       Date:  2008-12-12
View more
  15 in total

1.  Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.

Authors:  Zhan-Guo Gao; Ramachandran Balasubramanian; Evgeny Kiselev; Qiang Wei; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2014-05-20       Impact factor: 5.858

2.  Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor.

Authors:  Dong Guo; Suzanne N Venhorst; Arnault Massink; Jacobus P D van Veldhoven; Georges Vauquelin; Adriaan P IJzerman; Laura H Heitman
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 3.  Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.

Authors:  Rachel Dopart; Dai Lu; Aron H Lichtman; Debra A Kendall
Journal:  Drug Metab Rev       Date:  2018-01-21       Impact factor: 4.518

Review 4.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

5.  Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Mol Pharmacol       Date:  2017-09-01       Impact factor: 4.436

Review 6.  Trends in GPCR drug discovery: new agents, targets and indications.

Authors:  Alexander S Hauser; Misty M Attwood; Mathias Rask-Andersen; Helgi B Schiöth; David E Gloriam
Journal:  Nat Rev Drug Discov       Date:  2017-10-27       Impact factor: 84.694

Review 7.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

Review 8.  Selective Modulation of Dynamic Protein Complexes.

Authors:  Julie M Garlick; Anna K Mapp
Journal:  Cell Chem Biol       Date:  2020-08-11       Impact factor: 8.116

9.  Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.

Authors:  Atsushi Suzuki; Akiyoshi Kunugi; Yasukazu Tajima; Noriko Suzuki; Motohisa Suzuki; Masashi Toyofuku; Haruhiko Kuno; Satoshi Sogabe; Yohei Kosugi; Yasuyuki Awasaki; Tomohiro Kaku; Haruhide Kimura
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

10.  Chemical, target, and bioactive properties of allosteric modulation.

Authors:  Gerard J P van Westen; Anna Gaulton; John P Overington
Journal:  PLoS Comput Biol       Date:  2014-04-03       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.